By Jan Hoffman — 2016
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.
Read on www.nytimes.com
CLEAR ALL
Encounters with inter-dimensional beings, atheists discovering belief, and the bizarre world of DMT-induced entities. A trip to the fringes of psychedelic science.
1
Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.